GILD vs POST · P/E 18, rev $29.44B vs P/E 15, rev $8.16B
Gilead Sciences Inc (GILD) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the GILD and POST stock pages for the full models.
Not investment advice.